العربية
English
Feasibility Study for a Pharmaceutical and Nutritional Supplement Production Plant
Feasibility Study for a Pharmaceutical and Nutritional Supplement Production Plant
The project aims to establish a factory specialized in the production of pharmaceuticals and nutritional supplements according to the highest quality and safety standards, in compliance with the requirements of the Saudi Food and Drug Authority (SFDA) and international standards (GMP). The factory includes units for the production of general human medicines (such as medications and antibiotics) as well as natural nutritional supplements such as vitamins, minerals, and proteins. It targets the local market and markets in the Gulf countries.
Investment Opportunity Content
Targeted Products and Services
Targeted Products and Services
Human Medicines (Tablets, Capsules, Syrup)
Natural Nutritional Supplements (Omega-3, Vitamin D, Zinc, Calcium, etc.)
Immunity and Energy Support Products
Clinically Supported Herbal Formulas (Modern Alternative Medicine)
OEM – Private Label Services
Products for Athletes and the Elderly
Topical Therapeutic Preparations such as Creams and Ointments
Demand and Market Analysis
Demand and Market Analysis
The United Kingdom is poised for economic growth in healthcare spending, with the pharmaceutical market expected to exceed SAR 50 billion by 2030.
There is a strong government drive toward localizing pharmaceutical industries, reducing reliance on imports, and increasing health awareness among the population, leading to a significant increase in dietary supplement consumption.
The dietary supplement market in Saudi Arabia is growing at a compound annual rate of over 10%.
Increased reliance on preventative treatment and dietary supplements during and after the COVID-19 pandemic.
Investment Benefits
Investment Benefits
Government support programs such as “Made in Saudi Arabia” and “Nedlab” can provide a clear and organized regulatory environment through the Food and Drug Authority, reducing import and distribution costs for manufacturers, making it possible, compared to importers, to expand significantly from the local market to the Gulf and Middle Eastern markets. The project aligns with the objectives of Saudi Vision 2030 to achieve food security.
Project Features
Project Features
Factory design in accordance with global GMP standards
Multiple production lines allow for flexibility in meeting demand for various types of medicines and supplements
Possibility of obtaining supply contracts with major pharmacies and hospitals
Opportunity for innovation in natural supplements and extracts from local plants
Building a Saudi brand capable of competing with importers
Estimated Financial Indicators
Estimated Financial Indicators
The expected capital investment to establish a pharmaceutical and nutritional supplement factory is estimated to range between 60 and 120 million Saudi riyals, depending on the production capacity and technologies used. The project is expected to achieve an annual return on investment of 13 to 18% due to the growing demand for medical products and supplements. The study also indicates that the capital payback period ranges between 5 and 7 years from the start of operation.
Request a Consultation
As an ambitious entrepreneur, we partner with you to pave the way for success, ensuring exceptional results and a lasting impact.
Book an Appointment
With our expert consulting team, we stand by your side as dedicated partners in turning your vision into reality.